Award

Delivery Order #SPE2D326F6312

Short-Term Delivery Order for ADACEL TDAP Vaccine by DMS Pharmaceutical

Buyer

Defense Logistics Agency

Award Amount

$309.99

Ceiling

$309.99

Awarded

February 20, 2026

Period of Performance

Feb 20, 2026 – Feb 23, 2026

Identifier

SPE2D326F6312

NAICS

325411

This award is a delivery order under an existing long-term indefinite delivery, indefinite quantity (IDIQ) contract with DMS Pharmaceutical Group Inc., a specialized pharmaceutical manufacturer and distributor. The contract procures a specific vaccine product, the ADACEL TDAP 0.5ML vial, used for immunization against tetanus, diphtheria, and pertussis. This procurement supports public health initiatives by ensuring the availability of critical vaccines for government healthcare programs. The scope involves delivering the specified vaccine within a short, defined period of a few days, highlighting an urgent or routine replenishment of vaccine stocks. The delivery order is linked to a sizeable foundational contract established to provide injectable pharmaceuticals flexibly over a multi-year timeline. Although competitive or sole-source details are not specified for this particular order, it operates under the terms of the overarching IDIQ agreement that facilitates adaptable procurement. The place of performance is in Park Ridge, Illinois, and the contract's brief duration indicates a focused supply task within a larger framework of pharmaceutical support.

Description

4570898317!ADACEL TDAP VIAL 0.5ML

View original record